Quick Overview: CEO Chris Moreau discusses the recent Ifendprodil transaction with Seyltx and Interview with Christopher Moreau, CEO of Interview with Christopher J. Moreau, CEO of
Algernon Pharmaceuticals Plans Phase 2 - Detailed Overview & Context
CEO Chris Moreau discusses the recent Ifendprodil transaction with Seyltx and Interview with Christopher Moreau, CEO of Interview with Christopher J. Moreau, CEO of